Stopped Before it Started: The $2 Generic Drug List | 03.18.2025
The Trump administration has officially ended efforts to launch a $2 generic drug discount program for Medicare enrollees. The program, initially developed under the Biden administration and first previewed in 2023, aimed to make about 150 common generic drugs available for just $2 per prescription. CMS officials estimated that this initiative could have benefited 32 million Medicare Part D enrollees, helping them save on essential medications. However, with the administration rescinding support for the project, the program will no longer move forward.
Key takeaways include:
No $2 generic drug list* under Medicare Part D.
Potentially higher out-of-pocket costs for common medications, plan-dependent.
Limited access to ultra-low-cost prescriptions - again, plan-dependent.
Continued reliance on plan formularies, which vary in coverage and pricing.
Unclear reasons for canceling the program or how much money CMS expects to save.
For Medicare beneficiaries, this means carefully reviewing your Part D drug plan is more important than ever. Many plans do offer low-cost generic drugs, but coverage varies widely.
With his expertise and access to 15 insurance carriers, Mark can help you navigate your options. If you’re concerned about drug costs or need a plan review, schedule a consultation today to ensure you have the right coverage for your situation.
*From CMS.gov: Medicare $2 Drug List Model List RFI Sample Drug List (RFI = Request for Information, which means these were drugs under consideration.)
